60% Of Americans Are Skipping Medical Visits To Save Money

The rapid rise in health care costs is forcing many Americans to make tough choices. Nearly 6 in 10 patients have skipped or delayed medical care because of the cost, and the same percentage has had difficulty paying a medical bill in full or on time, a new survey from the health care finance company Alphaeon found.

“Too often, cost stands between patients, their dependents and pets, and the care they need,” said Thomas Ervesun, the company’s CEO. “Pricing shouldn’t deter people from getting care. While health care providers might not be able to lower prices, they can do more to make paying for care easier.”

Nearly 9 in 10 survey respondents said they would like to have an easier way to pay medical bills, and 60% said they have paid with a credit card. Despite 62% of respondents saying they were aware that some providers offer patient financing, only half have a general idea of how it works and just 18% said they understand it.

More than half would be extremely or somewhat likely to use patient financing offered by a provider and strongly or somewhat agree with the statement that “patient financing makes health care more affordable and accessible.”

The leading types of care they would most like to be able to finance are:

  • Dental, 70%
  • Veterinary, 33%
  • Cosmetic, 18%
  • Audiology, 9%
  • Other, 21.2%

“Health care has not been as innovative or patient-friendly as other industries in its approach to financing,” Ervesun said. “Offering third-party financing not only makes it possible for patients to get necessary care when they need it but also improves revenue for practices while strengthening patient loyalty.”

A 2025 survey of health care costs found similar results. More than one-third of insured U.S. adults said they had skipped or postponed necessary medical care or medications in the past 12 months because of cost, according to Imagine360. Among respondents, 38% said they delayed or skipped care because of cost, a 41% increase over the 27% reported in 2023 in a separate study.

“Businesses across the country are faced with the daunting task of either passing increasing health care costs to their employees or making significant cuts to other business expenses,” Jeff Bak, CEO and president of Imagine360. “The survey indicates that rising costs lead to Americans not accessing the care they need or leaving their place of employment to find affordable health benefits.”

 

Source Link

Recommended Articles

CMS Finalizes Major Changes To ACA Exchanges, Including Greater Access To Catastrophic Plans

Editor’s Note: Covered California is a State-Based Marketplace (SBM). For details on how these new rules will impact Covered California and other SBMs we recommend the following Princeton University linked report: (Broker rule changes appear at the bottom of the Princeton analysis.) https://shvs.org/wp-content/uploads/2025/06/SHVS_2025-Final-Marketplace-Integrity-Rule.pdf.   The Trump administration on Friday finalized a major rule reshaping the ...

Read More

Eroding ACA Enrollment Portends Higher Insurance Rates

Enrollment in the Affordable Care Act continues to erode as some customers struggle to make premium payments, with the declining numbers churning market uncertainty for insurers. In response, insurers are likely to raise rates again next year, following this year’s larger-than-typical hikes. Sign-ups were already down in January by about 1.2 million from last year’s record enrollment. For ...

Read More

White House Adds Generic Drugs To Direct-To-Consumer TrumpRx Site

The Trump administration on Monday said it is adding generic medications to its direct-to-consumer drug sales website, TrumpRx, in a bid to expand a platform that is key to his administration’s efforts to lower prescription drug costs in the U.S. The administration is adding more than 600 generic drugs to the site, President Donald Trump said at an event ...

Read More

Supreme Court Rejects Big Pharma Appeals Challenging Negotiated Drug Prices In Medicare

The US Supreme Court on Monday rejected a series of appeals from several of the nation’s largest drugmakers challenging a program that is expected to save taxpayers and the federal government billions of dollars by requiring the companies to negotiate with Medicare on the prices for some of their most popular drugs. The court’s decision to deny ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square